← Back to Clinical Trials
Recruiting NCT06969456

NCT06969456 Managing Chronic Spinal Pain With Exercise and Neuromodulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06969456
Status Recruiting
Phase
Sponsor Fundación Universidad Católica de Valencia San Vicente Mártir
Condition Spinal Pain Syndrome
Study Type INTERVENTIONAL
Enrollment 42 participants
Start Date 2025-10-27
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
ExerciseTDCSShamTDCS

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 42 participants in total. It began in 2025-10-27 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Chronic spinal pain is a multifaceted condition frequently characterized by an absence of discernible structural causes, manifesting in symptoms such as significant disability and diminished quality of life. Persistent Spinal Pain Syndrome Type 2 (PSPS-T2) represents a common variant, implicating both peripheral and central nervous system mechanisms. This study investigates the synergistic effects of transcranial direct current stimulation (tDCS) in conjunction with motor control exercises on PSPS-T2 patients who have not responded to conventional treatments. A randomized controlled trial (RCT) will be conducted to compare an experimental group (tDCS + exercise) with a control group (exercise only), with the objective of enhancing functionality, alleviating pain levels, and improving psychological well-being. The findings may contribute to the development of more effective, patient-centered treatment strategies.

Eligibility Criteria

Inclusion Criteria: * Have a diagnostic of PSPS-T2 * Neuropathic pain (DNA4 ≥ 4) * Patients older than 18 years * ≥ 6 months with pain * VAS score ≥ 7 Exclusion Criteria: * Previous or programmed surgeries in abdominal area * Pregnant or lactating * Severe fractures or pathologies * Spine structural deformity * Neurologic or psychiatric issues

Contact & Investigator

Central Contact

Borja Huertas Ramirez Juan Vicente Mampel, Phd Studente

✉ borja.huertas@mail.ucv.es

📞 +34 684098665

Frequently Asked Questions

Who can join the NCT06969456 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Spinal Pain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06969456 currently recruiting?

Yes, NCT06969456 is actively recruiting participants. Contact the research team at borja.huertas@mail.ucv.es for enrollment information.

Where is the NCT06969456 trial being conducted?

This trial is being conducted at Valencia, Spain.

Who is sponsoring the NCT06969456 clinical trial?

NCT06969456 is sponsored by Fundación Universidad Católica de Valencia San Vicente Mártir. The trial plans to enroll 42 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology